Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Idexx Laboratories (IDXX)

Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 42,702,432
  • Shares Outstanding, K 82,587
  • Annual Sales, $ 3,661 M
  • Annual Income, $ 845,040 K
  • 60-Month Beta 1.33
  • Price/Sales 11.50
  • Price/Cash Flow 44.32
  • Price/Book 26.77
Trade IDXX with:

Options Overview Details

View History
  • Implied Volatility 24.00% ( -0.06%)
  • Historical Volatility 21.72%
  • IV Percentile 4%
  • IV Rank 8.63%
  • IV High 46.25% on 08/05/24
  • IV Low 21.89% on 05/17/24
  • Put/Call Vol Ratio 3.00
  • Today's Volume 1,516
  • Volume Avg (30-Day) 207
  • Put/Call OI Ratio 1.43
  • Today's Open Interest 5,840
  • Open Int (30-Day) 6,340

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 2.69
  • Number of Estimates 6
  • High Estimate 2.71
  • Low Estimate 2.67
  • Prior Year 2.53
  • Growth Rate Est. (year over year) +6.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
465.53 +8.97%
on 09/05/24
530.60 -4.39%
on 09/19/24
+13.30 (+2.69%)
since 08/20/24
3-Month
446.28 +13.68%
on 08/05/24
530.60 -4.39%
on 09/19/24
+11.35 (+2.29%)
since 06/20/24
52-Week
372.50 +36.19%
on 11/01/23
583.39 -13.04%
on 03/01/24
+51.96 (+11.41%)
since 09/20/23

Most Recent Stories

More News
How Is IDEXX Laboratories' Stock Performance Compared to Other Healthcare Stocks?

IDEXX Laboratories underperformed the broader healthcare sector, but Wall Street analysts remain moderately optimistic about the stock’s prospects.

IDXX : 506.74 (-2.00%)
IHI : 59.12 (-0.45%)
TMO : 613.69 (-1.06%)
Are Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb or Sink?

IDEXX Laboratories has underperformed the broader market over the past year, yet analysts remain moderately bullish on the stock’s prospects.

IDXX : 506.74 (-2.00%)
$SPX : 5,702.55 (-0.19%)
$SPX : 5,702.55 (-0.19%)
XHE : 90.59 (-0.40%)
Idexx: Q2 Earnings Snapshot

Idexx: Q2 Earnings Snapshot

IDXX : 506.74 (-2.00%)
IDEXX Laboratories Earnings Preview: What to Expect

IDEXX Laboratories will unveil its Q2 earnings next month, and analysts anticipate a single-digit bottom-line growth.

IDXX : 506.74 (-2.00%)
$SPX : 5,702.55 (-0.19%)
XLV : 155.28 (-0.41%)
IDEXX Laboratories Stock: Is IDXX Underperforming the Healthcare Sector?

IDXX Laboratories has recently underperformed the Healthcare sector, but Wall Street analysts are moderately optimistic about the stock’s prospects.

IDXX : 506.74 (-2.00%)
XLV : 155.28 (-0.41%)
ZTS : 192.64 (-0.31%)
IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing Pancreatitis

/CNW/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announces the launch of the Catalyst® Pancreatic Lipase Test, a...

IDXX : 506.74 (-2.00%)
Idexx: Q1 Earnings Snapshot

Idexx: Q1 Earnings Snapshot

IDXX : 506.74 (-2.00%)
IDEXX Launches Velloâ„¢, an Innovative Pet Owner Engagement Software Solution, Streamlining How Practices and Clients Connect

/CNW/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announces the launch of Vello, a software solution that...

IDXX : 506.74 (-2.00%)
Stocks Finish Lower as Rate Cut Hopes Recede on Hawkish Fed

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Monday closed down -0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.71%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...

$SPX : 5,702.55 (-0.19%)
SPY : 568.01 (-0.22%)
$DOWI : 42,063.36 (+0.09%)
DIA : 420.57 (+0.10%)
$IUXX : 19,791.49 (-0.24%)
QQQ : 482.42 (-0.19%)
APD : 287.98 (+0.09%)
ADM : 61.36 (-1.75%)
CHTR : 330.40 (-0.28%)
HUM : 310.41 (-0.51%)
GFS : 39.41 (-3.92%)
ZS : 172.71 (+0.08%)
Stocks Fall as Bond Yields Jump on Hawkish Fed Comments and Strong ISM Services Report

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.76%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.98%....

$SPX : 5,702.55 (-0.19%)
SPY : 568.01 (-0.22%)
$DOWI : 42,063.36 (+0.09%)
DIA : 420.57 (+0.10%)
$IUXX : 19,791.49 (-0.24%)
QQQ : 482.42 (-0.19%)
APD : 287.98 (+0.09%)
ZS : 172.71 (+0.08%)
HUM : 310.41 (-0.51%)
MCD : 296.83 (+1.01%)
CHTR : 330.40 (-0.28%)
BA : 153.29 (-0.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

IDEXX Laboratories, Inc. is a developer, manufacturer and distributer of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care...

See More

Key Turning Points

3rd Resistance Point 541.47
2nd Resistance Point 536.03
1st Resistance Point 526.55
Last Price 506.74
1st Support Level 511.63
2nd Support Level 506.19
3rd Support Level 496.71

See More

52-Week High 583.39
Last Price 506.74
Fibonacci 61.8% 502.83
Fibonacci 50% 477.95
Fibonacci 38.2% 453.06
52-Week Low 372.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar